Evidence map›Paper›PMID 31744014›Full record

ArticleJournal of Huntington's disease2020

Responsiveness to Change Over Time: An Examination of the Neuro-QoL Social Function Measures in Persons with Huntington's Disease.

Noelle E Carlozzi, Nicholas R Boileau, Elizabeth A Hahn, Stacey K Barton, David Cella, Michael K McCormack, Rebecca E Ready

Open access · greenAbstract read
In one paragraph

Article in Journal of Huntington's disease, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact, top 86% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Noelle E CarlozziDepartment of Physical Medicine and Rehabilitation, University of Michigan, Ann Arbor, MI, USA.
Nicholas R BoileauDepartment of Physical Medicine and Rehabilitation, University of Michigan, Ann Arbor, MI, USA.
Elizabeth A HahnDepartment of Medical Social Sciences, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Stacey K BartonDepartment of Neurology, Washington University School of Medicine, St. Louis, MO, USA.
David CellaDepartment of Medical Social Sciences, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Michael K McCormackDepartment of Psychiatry, Rutgers-Robert Wood Johnson Medical School, Piscataway, NJ, USA.
Rebecca E ReadyDepartment of Psychological and Brain Sciences, University of Massachusetts, Amherst, MA, USA.
Northwestern University · USUniversity of Michigan–Ann Arbor · USRowan University · USUniversity of Massachusetts Amherst · USWashington University in St. Louis · US

Funding

Michigan Institute for Clinical and Health Research (MCHR)UL1TR000433 · NCATS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MASHOUR, GEORGE ALEXANDER · 2012 to 2016
$49.9M
NEUROBIOLOGICAL PREDICTORS OF HUNTINGTON'S DISEASER01NS040068 · NINDS · UNIVERSITY OF IOWA · PI PAULSEN, JANE S · 2001 to 2013
$48.5M
Validation of the HD-HRQOL (Huntington disease quality of life measure)R01NS077946 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CARLOZZI, NOELLE E. · 2012 to 2016
$3.2M
Preparing for preventive clinical trials in Huntington's diseaseU01NS105509 · NINDS · UNIVERSITY OF WISCONSIN-MADISON · PI PAULSEN, JANE S · 2020 to 2025
$2.5M
NCATS NIH HHS UL1 TR000433NINDS NIH HHS R01 NS040068NINDS NIH HHS R01 NS077946NINDS NIH HHS U01 NS105509
6 · The paper itself

Abstract

backgroundSocial health is an important concern in persons with Huntington's disease (HD); however, there is little literature examining this construct in this population.

objectiveWhile cross-sectional data supports the clinical utility of two Neuro-QoL social health measures in persons with HD, data is still needed to establish their longitudinal validity.

methodsParticipants (N = 358) completed baseline and at least one follow-up (12- and 24-month) assessment that included the completion of Neuro-QoL Social Health computer adaptive tests (CATs) and short forms (for Ability to Participate in Social Roles and Activities [SRA] and Satisfaction with SRA). Test-retest reliability was examined using intra class correlations, and one-way ANOVAs with Bonferroni post-hoc contrasts were used to determine whether there were group differences among premanifest, early- and late-stage HD participants on the Social health measures. In addition, standardized response means were used to examine longitudinal responsiveness, and mixed or general linear models were used to examine change over time (relative to self-reported change on an associated anchor item about social health and clinician-rated change based on Total Functional Capacity scores from the UHDRS).

resultsTest-retest reliability of the measures was excellent (ICCs ranged from 0.82 to 0.87 across the different measures) and persons with greater disease burden reported more problems with social health than those at earlier stages in the disease process (all p < 0.0001). Responsiveness was supported for all measures except the Ability to Participate in SRA CAT; participants who had self-reported or clinician-rated declines in health generally had 12- and 24-month declines on the Neuro-QoL measures.

conclusionsFindings indicate that these measures may be useful for studies attempting to assess change in social health over time.

Indexed as

Disease ProgressionPatient Reported Outcome MeasuresPsychosocial FunctioningQuality of LifeSocial SkillsAdultDiagnosis, Computer-AssistedFemaleFollow-Up StudiesHumansHuntington DiseaseLongitudinal StudiesMaleMiddle AgedNeuropsychological TestsReproducibility of Resultshealth-related quality of lifeHuntington’s diseasepatient-reported outcomessocial healthvalidity

Identifiers

PMID31744014
PMCPMC7799504
OpenAlexW2986175713

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.